HF 5147·MN·house
Income and corporate franchise tax provisions modified, and addition for pharmaceutical marketing expenses required.
FailedFiled May 14, 2026
Sponsor: Bierman
Latest Action
Introduction and first reading, referred to
May 14, 2026
Summary
The bill amends Minnesota tax statutes to treat the federal deduction for direct‑to‑consumer pharmaceutical marketing as an addition, not a deduction, for state income and corporate franchise taxes. It applies to any taxpayer, including drug manufacturers, that claim the deduction under Internal Revenue Code §162. The change becomes effective for taxable years beginning after December 31, 2026.
AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.
Topics
Track this bill
Get an email when HF 5147 moves: committee action, floor votes, amendments and hearings. Free, no card.
Track HF 5147 freeOr ask your AI assistant about HF 5147 directly:
Add to Claude, ChatGPT or Cursor